{
    "SPADE_UN_22290": {
        "Sequence Information": {
            "Peptide Name": "IBP-CP24",
            "Sequence": "DCAWHLGELVWCTMTWEEWDKKIEEYTKKIEELIKKS",
            "Sequence Length": 37,
            "Biological Activity": [
                "Antiviral"
            ],
            "Binding Target": "1. gp41\n2. Virus entry",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "Q5DP94",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q5DP94",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "IgG Fc-binding Motif-Conjugated HIV-1 Fusion Inhibitor Exhibits Improved Potency and in Vivo Half-Life: Potential Application in Combination With Broad Neutralizing Antibodies.",
                    "Pubmed ID": "31805154",
                    "Reference": "PLoS Pathog. 2019;15:e1008082",
                    "Author": "Bi W, Xu W, Cheng L, Xue J, Wang Q, Yu F, Xia S, Li G, Qin C, Lu L, Su L, Jiang S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31805154"
                }
            ],
            "Mass": 4600.25,
            "PI": 4.91,
            "Net Charge": -2,
            "Hydrophobicity": -0.77,
            "Frequent Amino Acids": "EKW",
            "Absent Amino Acids": "FNOPQRU",
            "Basic Residues": 7,
            "Acidic Residues": 9,
            "Hydrophobic Residues": 11,
            "Polar Residues": 26,
            "Positive Residues": 7,
            "Negative Residues": 9,
            "SPADE ID": "SPADE_UN_22290",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_22289",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSDCAWHLGELVWCT"
                },
                {
                    "SPADE_ID": "SPADE_UN_22291",
                    "Similarity": 1.0,
                    "Sequence": "DCAWHLGELVWCT"
                },
                {
                    "SPADE_ID": "SPADE_UN_14197",
                    "Similarity": 1.0,
                    "Sequence": "MTWEEWDKKIEEYTKKIEELIKKSQNQQ"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "HIV-1 IIIB(IC50 I=0.0059µM),HIV-1 IIIB(IC50 F=0.01959µM),HIV-1 BaL(IC50 I=0.00257µM),HIV-1 JRCSF(IC50 I=0.0063µM),HIV-1 NL4-3 V38A(IC50 I=0.0492µM),HIV-1 NL4-3 D36G(IC50 I=0.0318µM),Human T cell leukemia MT-2(no activity data),Acute myeloid leukemia AML-M7(no activity data),HIV-1(IC50 I=0.011-0.0262µM),HIV-1 PsV(IC50 I=0.0113-0.0332µM),HIV-1 JRCSF(IC50 I=0.04142µM)"
        }
    }
}